Cargando…

Effects of biological therapies on chronic rhinosinusitis in severe asthmatic patients

OBJECTIVE: The introduction of monoclonal antibody (mAb) therapies represents a promising treatment for refractory chronic rhinosinusitis (CRS). We assessed the effects of selected mAbs (omalizumab, mepolizumab, benralizumab) on CRS in severe asthmatic patients in a real-life setting. METHODS: A pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Bandi, Francesco, Gallo, Stefania, Preti, Andrea, Mozzanica, Francesco, Visca, Dina, Marelli, Margherita, Maddalone, Enrico, Gambarini, Cinzia, Vaghi, Adriano, Spanevello, Antonio, Castelnuovo, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore Srl 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889250/
https://www.ncbi.nlm.nih.gov/pubmed/33558772
http://dx.doi.org/10.14639/0392-100X-N0716

Ejemplares similares